Shaping the Future of Multispecific Antibody Therapeutics

The multispecific antibodies stream at the PEGS Boston Summit will review the latest developments from engineering and platform innovations to preclinical and clinical advancement in this burgeoning field. This year will feature the design of novel constructs, the mitigation of toxicity and optimization of efficacy, the proliferation of conditional activation and masking strategies, and emerging approaches to improved targeting. Don’t miss out on the most significant forum of the year to learn about the latest trends and research results and meet face to face with leaders who are changing the future of biologics.

Conferences and Training Seminars Include:

May 11-12

TS: Intro to Multispecific Antibodies

May 12-13

Advancing Multispecific Antibodies and Combination Therapy to the Clinic

May 14-15

Engineering Bispecific and Multispecific Antibodies

Keynote and Featured Speakers:

A Novel T Cell Engager for Colorectal Cancer
JoAnn A. Suzich, PhD, Head, Research, Immunocore LLC

Engineering Multi-Pronged CAR T Cell Therapy for Cancer
Yvonne Y. Chen, PhD, Professor, Microbiology & Immunology & Molecular Genetics, University of California, Los Angeles

2026 PROGRAMS

View By:

• Display of Biologics
• Engineering Antibodies
• Machine Learning for Protein Engineering

• Antibodies for Cancer Therapy
• Emerging Targets for Oncology & Beyond
• Driving Clinical Success in Antibody-Drug Conjugates

• TS: Intro to Multispecific Antibodies
• Advancing Multispecific Antibodies
• Engineering Bispecific and Multispecific Antibodies

• Emerging T Cell Engagers
• Advances in Immunotherapy
• Next-Generation Immunotherapies

• Difficult-to-Express Proteins
• Optimizing Protein Expression
• Maximizing Protein Production Workflows

• ML and Digital Integration in Biotherapeutic Analytics
• Biophysical Methods
• Characterization for Novel Biotherapeutics

• TS: Intro to Immunogenicity
• Predicting Immunogenicity with AI/ML Tools
• TS: Bioassay Development and Analysis

• Biologics for Autoimmune Diseases
• Frontiers in Radiopharmaceutical Therapy
• Emerging Peptide Therapeutics

• ML and Digital Integration in Biotherapeutic Analytics
• Predicting Immunogenicity with AI/ML Tools
• Machine Learning for Protein Engineering